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ABSTRACT
Background and Objectives: We aimed to assess the usefulness of a threshold-based, 3-dimensional (3D) segmentation in 
comparison with the traditional 2-dimensional (2D) short axis-based method for measurement of epicardial fat volume with 
64-slice multidetector computed tomography (MDCT). Subjects and Methods: One hundred patients (52 males; mean 
age, 58.36±11.0 years) who underwent coronary CT angiography were enrolled in this study. The epicardial fat volume was 
measured using the two methods. The existing method was the 2D short axis-based method and the new method was the 
threshold-based 3D segmentation. Pearson’s correlation was used to compare the two measurement methods. We also assessed 
the relationship between the epicardial fat volume and coronary artery disease (CAD). Results: There were a strong corre-
lation between the epicardial fat volumes determined using the two methods (r=0.956, p<0.001). The mean overestimation of 
epicardial fat volume by the threshold-based 3D method was 59.89±12.00% compared to the 2D short-axis based method. 
Using the 3D method, the epicardial fat volume was significantly higher in the CAD group than in the controls (165.07± 
48.22 cm
3 vs. 108.39±48.03 cm
3, p<0.001). Conclusion: Threshold-based 3D segmentation is another easy and useful tool 
for measuring the epicardial fat volume. (Korean Circ J 2010;40:328-333)
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Introduction
Current studies suggest that epicardial fat plays an important 
role in the development of coronary artery disease (CAD).
1-6) 
Because epicardial fat directly surrounds the coronary arter-
ies and may secrete numerous pro-inflammatory hormones 
and cytokines, and thus induces coronary endothelial dys-
function.
7) To investigate the relationship between epicardial 
fat and CAD, it is important to measure epicardial fat accura-
tely. In several studies, epicardial fat has been measured us-
ing various tools, such as magnetic resonance imaging (MRI),
8) 
computed tomography (CT),
1-3)6)9-13) and echocardiography.
4)5) 
Several reports suggest that measurement of the epicardial fat 
volume using CT provides more objective results, as it is hi-
ghly reproducible and requires less scanning time.
1-3)6)9-13) How-
ever, the well-known, 2-dimensional (2D) short axis-based 
CT method is labor intensive and requires two steps.
1-3)6)9-13) 
The first step involves manually tracing the area of the epicar-
dial fat on each cross-sectional image. In the second step, the 
epicardial fat volume is determined as the sum of the epicar-
dial fat area.
Recently, multidetector CT (MDCT) has allowed the acqui-
sition of volumetric data sets during short scan times with easy 
3-dimensional (3D) volumetric measurement. In the present 
study, we used a simpler method using surface-shaded dis-
play (SSD) for determining the epicardial fat volume. This te-
chnique permits the manipulation of the 3D epicardial fat vol-
ume in real-time using various tools, cutting the adjacent st-
ructures, and estimating the epicardial fat volume rapidly.
14)15) 
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published, thus the purpose of this study was to assess wheth-
er or not threshold-based 3D segmentation could replace 
the 2D short axis-based method for assessing the epicardial 
fat volume, and to evaluate the association between epicar-
dial fat and CAD.
Subjects and Methods
Patient population
Between January and March 2008, we retrospectively in-
cluded 100 consecutive patients (52 males and 48 females; 
mean age, 58.36±11.0 years) who had undergone coronary 
CT angiography. The patient population included the follow-
ing diagnoses: atypical chest pain (n=46), angina pectoris (n= 
32), previous myocardial infarction (n=14), and high-risk CAD 
(n=71). We excluded patients with severe motion artifact 
during CT scan because the diagnostic accuracy of CAD was 
low. 
We retrospectively reviewed the clinical information that 
exhibits cardiovascular and metabolic risk factors, such as hy-
pertension, smoking, atypical chest pain, angina pectoris, and 
previous myocardial infarction. We obtained laboratory data, 
including serum triglycerides, total cholesterol, high density 
lipoprotein-cholesterol (HDL-C), low density lipoprotein-
cholesterol (LDL-C), and elevated plasma glucose while fast-
ing. All patients gave written informed consent, and our study 
protocol was approved by our local ethics committee. Also, we 
calculated the body mass index (BMI) as an indicator of pa-
tient obesity.
CT technique
Contrast-enhanced coronary CT angiography was quanti-
fied on retrospectively electrocardiography-gated cardiac CT 
scans using 64-slice MDCT (Lightspeed VCT; GE Health-
care, Milwaukee, WI, USA). The heart rates of the patients 
were measured 1 hour before the examination. If the heart 
rate exceeded 65 bpm, heart rate control was achieved with 
a beta-blocker {oral propranolol hydrochloride (Inderol), 40 
mg/tablet}, except for patients in whom beta-blockers were 
contraindicated. Our coronary CT angiography protocol was 
applied as follows: slice collimation, 64×0.625 mm; gantry 
rotation time, 0.35 seconds; pitch, 0.2; scan time, 0.4 second; 
table feed, 6 mm/second; tube voltage, 120 kV; and tube cur-
rent, 600 mAs. 
At the time of scanning, patients received 80 mL of contrast 
agent (Iopromide, Ultravist 300; Schering, Berlin, Germany) 
at a rate of 5.0 mL/s for 16 seconds, followed by 50 mL of sa-
line solution administered intravenously at a rate of 5.0 mL/s 
for 10 seconds. Injection was performed through an antecubi-
tal vein via an 18-gauge catheter. As soon as the attenuation in 
the ascending aorta reached the predefined threshold of 140 
Hounsfield units (HUs), the scan was initiated. Data acquisi-
tion was performed in a cranial-caudal direction from the 
tracheal bifurcation to the diaphragm.
Epicardial fat measurement
All patient imaging data were transferred to a dedicated 
workstation (Advantage Windows 4.3; GE Healthcare, Mil-
waukee, WI, USA). Epicardial fat was defined as the adipose 
tissue between the myocardium from the surface of the heart 
to the visceral pericardium. Epicardial fat measurement was 
performed in the phase of the cardiac cycle with the least mo-
tion, which was most frequently the mid-diastolic phase (75% 
of the R-R interval). The two assessments, including the 2D 
short axis-based method and the threshold-based 3D segmen-
tation were completed by one examiner blinded to any pre-
vious measurement of the epicardial fat volume. We calcu-
lated the time required for analysis by both methods.
Epicardial fat volume measurement using the 2-di-
mensional short axis-based method 
The epicardial fat volume was determined using the 2D sh-
ort axis-based method. This method is referred to as the 2D 
method. Reformatted images were obtained from the raw data 
of axial images to the 2D short axis views with 3-mm slice 
thickness and 3-mm intersection gaps. The stacks of the short 
axis views began at the diaphragm and extended to the pul-
monary valve. 
The pericardium was manually traced and a region of in-
terest defined by the histogram-based statistical program was 
placed (Fig. 1A). A CT attenuation threshold between -200 
and -30 HU was used to isolate the epicardial fat (Fig. 1B). Fi-
nally, the epicardial fat volume was obtained by multiplica-
tion with the section thickness.
Epicardial fat volume measurement using threshold-
based 3-dimensional segmentation 
We reconstructed the epicardial fat volume using thresh-
old-based 3D segmentation. This method is referred to as the 
3D method. Image segmentation was based on the same th-
reshold range as mentioned in the known method, which 
meant that all pixels other than this value were automatically 
removed. The epicardial fat volume in the 3D method was de-
fined as that located from the level of the pulmonary trunk to 
the diaphragm. The initial 3D volumetric data obtained was 
not only intrathoracic fat, but other fat tissue, such as fat sur-
rounding the pulmonary vein and airway structure and fat 
within the chest wall (Fig. 2A). The 3D epicardial fat volume 
in the workstation was manipulated using tools, such as zoom, 
pan, and rotation, around any axis and the adjacent structures 
were cut.
15) Also, the epicardial fat was referred to the axial slice 
and subtracted from the fat outside of the visceral pericardi-
um (Fig. 2B). Finally, the 3D epicardial fat volume was deter-
mined and the epicardial fat volume was automatically meas-330   Epicardial Fat Volume in Threshold-Based 3D-CT
ured (Fig. 2C). 
Coronary artery disease assessment
Among the CT data sets of all 10 reconstruction intervals, 
the best reconstruction interval containing the fewest mo-
tion artifacts was selected for further evaluation. Measure-
ments were performed using the same workstation programs. 
First, the presence of coronary artery stenosis was determined 
on the axial images, thin-slab, maximum intensity projections, 
and the curved multiplanar reformatted images. Next, semi-
quantitative assessment of the stenosis was based on the ratio 
of the minimal contrast lumen over the normal reference lu-
men of an unaffected distal lumen. The CAD group was de-
fined as stenosis >50% of the luminal area. The control group 
was defined as non-CAD and stenosis <50% of the luminal area.
Two cardiac radiologists interpreted the images in consen-
sus. The two radiologists who evaluated the CAD were blind-
ed to the epicardial fat volume. The mean heart rate during 
the MDCT was 64±9 bpm (range, 52-74 bpm).
Statistical analysis
Statistical Package for the Social Sciences (SPSS), version 
12.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical 
analyses. The values were expressed as the mean±standard 
deviation (SD) or number (percentage). For dichotomous 
variables, the proportions were compared using chi-square 
analysis. For continuous variables, the mean and SD were 
compared using Student’s unpaired t-test. To adjust the mean 
epicardial fat volume for BMI differences, we used analysis 
of covariance (ANCOVA, general linear model). We used 
Pearson’s correlation analysis for analysis of the comparison 
of two measurement methods and the relationship between 
the epicardial fat volume and metabolic syndrome. A p<0.05 
was considered to indicate significance in all analyses. 
Fig. 2. Epicardial fat volume measurement using threshold-based 3-dimensional (3D) segmentation as the new method. A: the initial 3D 
volumetric data obtained not only intrathoracic fat, but also extrathoracic fat tissue (CT attenuation range between -200 HU and -30 HU). B: 
for the accurate measurement of the epicardial fat volume, we compared it to the corresponding 2-dimensional axial image. C: surface 
shaded display image demonstrates 3D epicardial fat volume (gray color). HU: Hounsfield unit.
A   B   C  
A   B  
Fig. 1. Epicardial fat area measurement using 2-dimensional short axis-based method as the known method. A: on the short axis view, the re-
gion of interest (ROI; red line) is drawn around the pericardium in order to determine the epicardial fat area (green). B: the epicardial fat area 
is automatically measured by a histogram-based analysis (CT attenuation range between -200 HU and -30 HU). The epicardial fat area of 
this case is 735 m
2. HU: Hounsfield unit.Mi Jung Park, et al..   331
Results 
Clinical characteristics
Our study group consisted of 100 patients (age, 18-81 years; 
52 males and 48 females). The patients were divided into the 
following groups: CAD group (n=60); and control group (n= 
40). Table 1 showed the clinical and laboratory data of the 
CAD and control groups. Smoking, angina pectoris, fasting 
plasma glucose, total cholesterol, LDL-C, and triglycerides 
were among the risk factors that were significantly higher in 
the CAD patients.
Comparison of epicardial fat volume measured with 
two methods 
There was a strong correlation between the two methods 
for quantifying the epicardial fat volume (r=0.956, p<0.001) 
(Fig. 3). The correlation between the two methods did not 
differ significantly between the control and CAD groups (r= 
0.966 and r=0.948, respectively). The mean epicardial fat 
volume by the 3D method was significantly larger by the 2D 
method (89.04±35.11 cm
3 vs. 142.37±55.60 cm
3, p<0.001) 
because the measurement extent was different in the two 
methods. The mean overestimation of the epicardial fat vol-
ume was 59.89±12.00% by the new 3D method. The mean 
time required for analysis was significantly higher in the 2D 
method (26.3±8.3 minutes vs. 4.9±1.2 minutes, p<0.001).
Relationship of the epicardial fat volume and the pre-
sence of coronary artery disease 
The epicardial fat volume was significantly higher in the 
CAD group than the control group (3D method: 165.07± 
48.22 cm
3 vs. 108.39±48.03 cm
3, p<0.001; 2D method: 103.23± 
32.17 cm
3 vs. 68.52±28.70 cm
3, p<0.001). After adjustment 
for the BMI using ANCOVA, the CAD group had a signifi-
cantly higher epicardial fat volume than the control group 
(p<0.001).
Relationship between the epicardial fat volume and 
various parameters of metabolic syndrome
Table 2 represents the correlation of the epicardial fat vol-
ume and various parameters of metabolic syndrome. The epi-
cardial fat volume by the 3D method was significantly corre-
lated with the fasting plasma glucose (r=0.233), systolic blood 
pressure (r=0.144), diastolic blood pressure (r=0.189), HDL-
C (r=-0.187), triglycerides (r=0.234), and BMI (r=0.308). 
Discussion
In the present study, we assessed a simple estimation tech-
nique using threshold-based 3D segmentation for determin-
ing the epicardial fat volume. Although this technique has 
been used to subtract the left ventricle and lung in previous 
studies,
14)16) no study has been performed to subtract the epi-
cardial fat. There are differences in the attenuation between 
Table 1. Anthropometric and clinical characteristics of patients in the CAD and control groups
Control group (n=60) CAD group (n=40) p
Age (years) 055.33±13.84 060.38±10.21 0.164*
Gender (male, %) 23 (38) 25 (63) 0.734*
Hypertension (%) 29 (49) 19 (48) 0.938*
Smoking (%) 2 (3) 09 (23) <0.001*
Angina pectoris (%) 14 (24) 18 (45) <0.001*
Body mass index (kg/m
2) 023.72±2.90 025.38±2.870 0.417*
Fasting plasma glucose (mg/dL) 107.38±33.63 131.04±64.30 0.001*
Total cholesterol (mg/dL) 162.62±24.73 197.30±38.82 0.004*
HDL-C (mg/dL) 050.49±10.93 050.46±12.41 0.423*
LDL-C (mg/dL) 093.11±22.52 124.52±31.22 0.026*
Triglyceride (mg/dL) 096.92±39.93 163.11±67.82 0.002*
Values are expressed as the mean±SD for continuous variable or number (percentage) for discontinuous variables. *statistically significant 
(p<0.05). CAD: coronary artery disease, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol
Fig. 3. Correlation dot plot of the epicardial fat volume in both meth-
ods. The correlation dot plot shows the strong correlation of each 
epicardial fat volumes measured using the two different methods 
(r=0.956, p<0.001); the x-axis indicates the 3D volume measure-
ment (3D) and the y-axis denotes 2D short-axis based method (2D). 
2D: 2-dimensional, 3D: 3-dimensional.
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epicardial fat and other structures surrounding that the epi-
cardial fat. Our study compared two different methods for 
quantifying epicardial fat volume. The existing method is a 2D 
short axis-based method, and the new method is a 3D segmen-
tation method based on automated threshold-based analysis.
In previous studies, epicardial fat measurement on CT used 
the 2D short axis-based method.
1-3)6)9-13) A limitation of this me-
thod was the semi-automatic tracing of the pericardium in ev-
ery slice section, taking a long time for post-processing. The du-
ration of post-processing in the 2D method was 26.3±8.3 mi-
nutes in our study. Another limitation was that the absolute epi-
cardial fat volume can be different because previous reports 
used various slice thicknesses and intersection gaps.
1-3)6)9-13) 
The thick slice thickness induces a partial volume effect, 
thus the epicardial fat volume can be estimated inaccurately.
According to the development of a computer software pro-
grams, the threshold-based 3D segmentation algorithm suf-
ace shaded display is possible for assessing the epicardial fat 
volume. This algorithm consists of three steps.
14) The first step 
is the imaging itself.
14) The second step involves the fat region 
extracted from the CT images by gray-level thresholding.
14) 
The fat has a relatively low CT attenuation number compared 
to other soft tissue structures and bone. We labeled pixels in the 
epicardial fat with CT numbers between -200 and -30 HUs. 
The third step is the shading procedure and 3D reconstruc-
tion.
14) In the thorax, the CT number alone was not sufficient 
to distinguish the epicardial fat from the other surrounding 
tissues. The intrathoracic fat, including epicardial fat, has the 
same density in CT images, and the pericardium within the 
intrathoracic fat is not always well-defined in the 3D image. 
Thus, we compared the intrathoracic fat with the correspond-
ing axial, coronal, and sagittal images and subtracted the fat 
outside of the visceral pericardium effectively. When the epi-
cardial fat volume was measured using the 3D method, it took 
a long time, but gradually took less time (mean time, 4.9±1.2 
minutes). Also, this technique required minimal computing 
power, was easy to perform, and did not affect the slice thick-
nesses or intersection gaps because we obtained the 3D epi-
cardial fat volume based on a raw data of 0.625 mm thickness. 
Thus, we can obtain more objective results with the 3D meth-
od compared to 2D method. 
The epicardial fat volumes measured using the two meth-
ods were highly correlated, although the absolute amount of 
the epicardial fat volume differed between the two methods 
because of the differences in the extent of estimation. We de-
termined the right pulmonary artery and the pulmonary 
valve as cut-off points in the 3D and 2D methods. In the 3D 
method, we could not determine the exact location of the pul-
monary valve level, so we defined the right pulmonary ar-
tery as cut-off point. We found a considerably higher epicar-
dial fat volume using the 3D method (approximately 1.6-
fold). This result indicates that the new threshold-based 3D 
segmentation using SSD may be expected to be another good 
method replacing the previous 2D short-axis-based method, 
even with the difference in extent for measuring the epicar-
dial fat. We used the retrospectively contrast-enhanced coro-
nary CT angiography for measuring the epicardial fat, but 
another report used non-contrast CT images acquired for 
routine coronary calcium screening.
9) More comparative stud-
ies will be needed to determine the most accurate and feasible 
method for measuring epicardial fat. 
We also demonstrated a relationship between epicardial 
fat and CAD. The recent studies have shown that abdominal 
visceral fat is an important risk factor for CAD.
6)17)18) As epi-
cardial fat is a true visceral fat that becomes deposited around 
the heart, it may contribute to the progression of coronary 
atherosclerosis.
1-6) The previous reports demonstrate that the 
amount of epicardial fat is associated with CAD alone, and 
CAD and metabolic risk factors.
1-6)10)13) Our results showed that 
the epicardial fat volume was significantly higher in the CAD 
group than in the control group. A similar result was obtained 
after adjustment for BMI in our study. Also, the epicardial fat 
volume was significantly correlated with risk factors of CAD 
and metabolic syndrome. 
Some limitations of this study were as follows. First, our 
study population was pre-selected as we excluded patients 
who had undergone coronary stent or bypass surgery. There-
fore, patients with known CAD were excluded from our study. 
Because the stent itself has a thrombogenic effect, we thought 
that it would be affected by the accumulation of epicardial 
fat.
19) The epicardial fat can be removed and damaged during 
coronary artery bypass surgery.
20) Second, as mentioned ab-
ove, the threshold-based 3D segmentation algorithm has a 
potential limitation. In the thorax, the CT number alone was 
not sufficient to distinguish the epicardial fat from surround-
ing tissues. Because intrathoracic fat, including epicardial 
fat, has the same densities in CT images, the pericardium wi-
thin the intrathoracic fat is not always well-defined in the 3D 
image. Comparison with the corresponding axial image al-
lowed the effective subtraction of the fat outside of the vis-
ceral pericardium. This additional step needed more time by 
Table 2. Pearson's correlations between epicardial fat volume by 
3D method and various parameters of metabolic syndrome in the 
control and CAD groups 
r p
Fasting glucose -0.233 0.012
SBP -0.144 0.042
DBP -0.189 0.048
HDL-C -0.187 0.036
Triglycerides -0.234 <0.001
BMI -0.308 0.002
3D: 3-dimensional, CAD: coronary artery disease, SBP: systolic 
blood pressure, DBP: diastolic blood pressure, HDL-C: high den-
sity lipoprotein-cholesterol, BMI: body mass index Mi Jung Park, et al..   333
the 3D method, although it took less time compared to the 
2D method. Third, we did not use the same extent for meas-
uring the epicardial fat volume to compare the two methods. 
Thus, a direct comparison between the two methods was not 
possible in this study. Fourth, no standardized criterion was 
established to quantify the epicardial fat volume because pre-
vious reports used various extents and density ranges. A con-
sensus and a large amount of clinical data will be necessary 
for quantifying the epicardial fat volume. 
In summary, threshold-based 3D segmentation using the 
SSD technique is a feasible, convenient, and powerful tool to 
measure epicardial fat volume related to CAD.
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